Year archive

DSM-Firmenich AG — 2023 filings

All 14 regulatory filings released by DSM-Firmenich AG (DSFIR) in 2023, sourced directly from the official regulator.

14 Filings

2023 Period

2023 filings (14)

Filing	Released	Lang
dsm-firmenich Q3 2023 trading update Interim / Quarterly Report Q3 2023	2023-10-31	English
dsm-firmenich provides additional pro forma financial information for 2022 and 2023 Earnings Release H1 2023	2023-10-04	English
Interim / Quarterly Report 2023 Interim / Quarterly Report H1 2023	2023-08-03	English
dsm-firmenich reports H1 2023 results Earnings Release H1 2023	2023-08-02	English
dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome M&A Activity	2023-07-03	English
dsm-firmenich announces results of extraordinary general meeting of shareholders AGM Information	2023-06-30	English
Trading update and acceleration of strategic actions Earnings Release Q2 2023	2023-06-28	English
Trading update and acceleration of strategic actions Earnings Release Q2 2023	2023-06-28	English
DSM-Firmenich AG launches the sale of up to c. 6.7 million existing DSM-Firmenich ordinary shares through an accelerated bookbuild offering Share Issue/Capital Change	2023-05-25	English
DSM-Firmenich AG announces the successful placement of c. 6.7 million existing DSM-Firmenich ordinary shares through an accelerated bookbuild offering for a total amount of €733 million Share Issue/Capital Change	2023-05-25	English
FINAL RESULTS OF THE EXCHANGE OFFER: 96.1% OF DSM ORDINARY SHARES TENDERED M&A Activity	2023-05-11	English
DSM-Firmenich announces evolution of CEO structure per 1 September, following completion of the merger Board/Management Information	2023-05-11	English
dsm-firmenich launches as innovators in nutrition, health, and beauty Regulatory Filings	2023-05-11	English
COMPLETION OF CONTRIBUTION OF FIRMENICH SHARES TO DSM-FIRMENICH M&A Activity	2023-05-11	English